scholarly journals Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Chun-Hsien Chen ◽  
Chien-Hung Chen ◽  
Chih-Lang Lin ◽  
Chun-Yen Lin ◽  
Tsung-Hui Hu ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Hepatic Fibrosis ◽  
Real World ◽  
Pooled Analysis ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Safety And Efficacy ◽  
Compensated Cirrhosis

scholarly journals Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study

Clinics ◽  
2017 ◽  
Vol 72 (6) ◽  
pp. 378-385 ◽  
Author(s):  
LA Callefi ◽  
CA Villela-Nogueira ◽  
SB Tenore ◽  
D Carnaúba-Júnior ◽  
HS Coelho ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Protease Inhibitors ◽  
Multicenter Study ◽  
Real World ◽  
First Generation ◽  
Genotype 1 ◽  
Virus Genotype

Real‐world experience with Grazoprevir/Elbasvir in the treatment of previously “difficult to treat” patients infected with hepatitis C virus genotype 1 and 4

2020 ◽  
Vol 35 (7) ◽  
pp. 1238-1246 ◽  
Author(s):  
Dorota Zarębska‐Michaluk ◽  
Jerzy Jaroszewicz ◽  
Iwona Buczyńska ◽  
Krzysztof Simon ◽  
Beata Lorenc ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Real World ◽  
Genotype 1 ◽  
Virus Genotype
Sign in / Sign up

Export Citation Format

Share Document